The well-established PCa tumor cell line LNCaP [44] and its derivative LNCaP C4-2 [45] are known for high PSMA expression and served as PSMA-positive (PSMA+) xenografts [46,47,48,49,50]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.